Evidence map›Paper›PMID 28539087›Full record

ArticleJournal of diabetes science and technology2018

Artificial Intelligence Methodologies and Their Application to Diabetes.

Mercedes Rigla, Gema García-Sáez, Belén Pons, Maria Elena Hernando

2 registry-linked trialsAbstract read
In one paragraph

Article in Journal of diabetes science and technology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 37 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04053959 phase4completednot on this mapstarted 2019, after this paper: background citation

A Study to Assess the Effect and Safety of Artificial Intelligence Assisted Insulin Titration System on Glucose Control in Type 2 Diabetes Mellitus Patients: A Single-center, Open-labeled, Parallel, Randomized Controlled Trial

TypeinterventionalSponsorShanghai Zhongshan HospitalRan2019 to 2020Enrolled46ConditionsType 2 DiabetesArmsAI assisted insulin system, Physician based insulin regime
NCT04642378 nacompletednot on this mapstarted 2021, after this paper: background citation

Study to Assess the Efficacy and Safety of iNCDSS Assisted Insulin Dosage Titration System on Glucose Control in Type 2 Diabetes Mellitus Patients : a Muticenter, Single-blind, Randomized Controlled Study

TypeinterventionalSponsorShanghai Zhongshan HospitalRan2021 to 2022Enrolled149ConditionsType 2 DiabetesArmsiNCDSS based insulin regime, routine insulin treatment regime
3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Six Digital Health Technologies That Will Transform Diabetes.Journal of diabetes science and technology · 2023
    Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Computer Based Diagnosis of Some Chronic Diseases: A Medical Journey of the Last Two Decades.Archives of computational methods in engineering : state of the art reviews · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mercedes Rigla1 Endocrinology and Nutrition Department, Parc Tauli University Hospital, Sabadell, Spain.
Gema García-Sáez2 Bioengineering and Telemedicine Centre, Universidad Politécnica de Madrid, Spain.
Belén Pons1 Endocrinology and Nutrition Department, Parc Tauli University Hospital, Sabadell, Spain.
Maria Elena Hernando2 Bioengineering and Telemedicine Centre, Universidad Politécnica de Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the past decade diabetes management has been transformed by the addition of continuous glucose monitoring and insulin pump data. More recently, a wide variety of functions and physiologic variables, such as heart rate, hours of sleep, number of steps walked and movement, have been available through wristbands or watches. New data, hydration, geolocation, and barometric pressure, among others, will be incorporated in the future. All these parameters, when analyzed, can be helpful for patients and doctors' decision support. Similar new scenarios have appeared in most medical fields, in such a way that in recent years, there has been an increased interest in the development and application of the methods of artificial intelligence (AI) to decision support and knowledge acquisition. Multidisciplinary research teams integrated by computer engineers and doctors are more and more frequent, mirroring the need of cooperation in this new topic. AI, as a science, can be defined as the ability to make computers do things that would require intelligence if done by humans. Increasingly, diabetes-related journals have been incorporating publications focused on AI tools applied to diabetes. In summary, diabetes management scenarios have suffered a deep transformation that forces diabetologists to incorporate skills from new areas. This recently needed knowledge includes AI tools, which have become part of the diabetes health care. The aim of this article is to explain in an easy and plane way the most used AI methodologies to promote the implication of health care providers-doctors and nurses-in this field.

Indexed as

Artificial IntelligenceDecision Support Systems, ClinicalDiabetes MellitusMachine LearningHumansartificial intelligencedecision supportdiabetesmachine learning

Identifiers

PMID28539087
PMCPMC5851211

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.